AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Present at Bear Stearns Boston Biotech Confab and Friedman Billings Ramsey European Investor Conference SAN DIEGO, June 23 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Bear Stearns Boston Biotech Confab on Tuesday, June 28, 2005 at 8:00 a.m. ET in Boston and at the Friedman Billings Ramsey European Investor Conference on Wednesday, June 29, 2005 at 3:30 p.m. GMT in London. Ginger L. Graham, President and Chief Executive Officer of Amylin Pharmaceuticals, will be providing a corporate overview at the Bear Stearns Confab. Berthold Lensker, PhD, Executive Director, European Operations and New Product Planning of Amylin Pharmaceuticals, will be presenting at the Friedman Billings Ramsey conference. Both presentations will be webcast live, and recordings will be made available following each event. The webcasts and recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the presentations to register and download any necessary audio software. Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director, Investor Relations of Amylin Pharmaceuticals, Inc., +1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/

Copyright